Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MarrowMule: BMC for Knee Unicompartmental OA
NCT03790189Phase 1Unknown
- Sponsor
- Humanitas Research Hospital
- Start
- Jan 2019
- Primary completion
- Jul 2021
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of autologous bone marrow cell concentrate in osteoarthritis (OA), sponsored by Humanitas Research Hospital. Primary endpoint: International Knee Documentation Committee Subjective Score at 12 months. Status: unknown.
02
Drugs
autologous bone marrow cell concentrate
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03790189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03790189.